Clinical Trial Update: Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the oral N-acetylcysteine as an expectorant in patients with stable chronic bronchitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Wake Forest University | Conditions: Chronic Bronchitis | Phase 2 | Status: COMPLETED